CAMBRIDGE, England, March 19, 2010 (HSMN NewsFeed) — Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that product management authorisatio…
Biopharmaceuticals, Oncology, Regulatory
Mundipharma, Levact, bendamustine, non-Hodgkin’s lymphoma, leukemia, myeloma

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers”
Leave a Comment